EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effects of aspirin on dipyridamole disposition in vivo



The effects of aspirin on dipyridamole disposition in vivo



Thrombosis & Haemostasis 50(1): 129




(PDF emailed within 1 workday: $29.90)

Accession: 029339492

Download citation: RISBibTeXText



Related references

A comparison of the effects of aspirin and dipyridamole on platelet aggregation in vivo and ex vivo. Thrombosis Research 13(3): 517-530, 1978

Dipyridamole disposition after chronic administration: effect of aspirin. Thrombosis Research. Supplement 4: 137-143, 1983

Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study. Journal of the American College of Cardiology 24(5): 1181-1188, 1994

Effects of dipyridamole and aspirin on platelet cyclic amp levels and prostaglandin biosynthesis in vivo in patients with diabetes mellitus. Thrombosis & Haemostasis 42(1): 196, 1979

Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement danger of aspirin compared with dipyridamole. American Journal of Cardiology 51(9): 1537-1541, 1983

Cost-effectiveness analysis of antiplatelet therapy in the prevention of recurrent stroke in the UK. Aspirin, dipyridamole and aspirin-dipyridamole. Pharmacoeconomics 16(5 Pt 2): 577-593, 2000

Platelet survival in coronary patients good response to dipyridamole plus aspirin partial response to low dose aspirin with or without dipyridamole implications for trials. American Heart Association Monograph (101): III-105, 1983

Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial. Lancet, 2017

Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: Patency and clinical outcome at 1 year. Journal of the American College of Cardiology 24(5): 1181-1188, 1994

Effect of dipyridamole and aspirin on platelet adherence to damaged rabbit aortas in vitro and in vivo. Federation Proceedings 37(3): 260, 1978

Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation and red cell deformability ex vivo in man. British Journal of Haematology 76(SUPPL 1): 39, 1990

Interaction of platelets with subendothelium in humans treated with dipyridamole and dipyridamole associated to low doses of aspirin. Thrombosis & Haemostasis 50(1): 375, 1983

Efficacy of dipyridamole as prophylaxis for stroke and the added value of dipyridamole in combination with aspirin. Platelets 7(1-2): 7-8, 1996

Effect of dipyridamole alone and in combination with aspirin on whole blood platelet aggregation, PGI2 generation, and red cell deformability ex vivo in man. Cardiovascular Research 25(3): 177-183, 1991

Combined dipyridamole and aspirin pellet formulation for improved oral drug delivery. Part 2: In-vivo evaluation and stability. Journal of Microencapsulation 13(4): 395-405, 1996